Once-daily dosing |
▸ Higher peak concentrations lead to more rapid and higher (initial) bacterial kill ▸ Toxicity is not increased because aminoglycoside uptake in the kidney and ear is saturable ▸ Higher peaks prolong ‘postantibiotic’ effect (continued suppression of bacterial growth after drug administration stops and serum concentrations are below the minimum inhibitory concentration) ▸ Lower predose concentrations reduce toxicity9 ▸ Longer ‘drug-free’ periods help reduce/reverse adaptive resistance (form of resistance developing after initial exposure of bacteria to aminoglycoside)10
|
▸ If drug clearance is high, ‘no-drug’ (untreated) periods between doses could result in clinically significant bacterial regrowth10 ▸ Standard once-daily doses, high doses should be avoided in children over 1 month of age with creatinine clearance <20 mL/min/1.73 m2
|
Multiple-daily dosing |
|
▸ Not appropriate for patients with reduced renal function (creatinine clearance <20 mL/min/1.73 m2), or neonates, due to insufficient time between doses to clear the drug3 ▸ More time-consuming and costly in clinical practice
|